Greenland Mines Ltd Dossier
Qualitative Analysis
Business overview
Greenland Mines Ltd (NASDAQ: GRML), formerly known as Klotho Neurosciences, Inc., is a dual-division company operating in natural resources and biotechnology. The Mining division is focused on the exploration and development of its flagship Skaergaard Project in southeast Greenland, which is one of the world's largest undeveloped gold, palladium, and platinum deposits. Additionally, the company is pursuing the acquisition of the Sarfartoq rare earth project in southwest Greenland to expand its critical minerals portfolio. The Biotech division focuses on developing cell and gene therapies for neurodegenerative and age-related disorders, including its KLTO-202 program for amyotrophic lateral sclerosis (ALS).
Research as of 24 Jul 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Building a diversified platform that links resource development in Greenland with downstream processing, logistics infrastructure, and industrial markets in Europe and North America.
Expected impact: Establishes a Western-aligned critical minerals corridor linking high-value magnet rare earths at Sarfartoq and palladium-gold-platinum at Skaergaard with allied downstream jurisdictions.
An integrated technical field program encompassing resource expansion drilling, geotechnical characterization, environmental baseline work, and collection of a bulk sample for processing flowsheet development.
Expected impact: Strengthens the technical foundation of the project and advances Skaergaard toward future open-pit evaluation and broader development studies.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
To acquire 100% of the Sarfartoq Rare Earths Project in southwest Greenland, adding an advanced magnet rare earths asset rich in neodymium and praseodymium to complement the Skaergaard project.
Financial impact: Consideration consists of US$20 million in cash and US$15 million in newly issued Greenland Mines common shares.
Strategic Partnerships
Provides Greenland Mines with an initial 9.9% equity position in AnorTech (with an option to increase to 19.9%) and exposure to sustainable alumina, high-purity alumina, and related midstream processing opportunities.
Terms: Greenland Mines issued 12,400,000 common shares (valued at approximately US$3.5 million at closing) in exchange for 19,958,503 common shares of AnorTech.
Neo Performance Materials secures offtake rights for up to 60% of future Sarfartoq ore or mineral concentrate production, connecting an upstream Greenlandic source of Nd-Pr feedstock to Neo's downstream magnet platform.
Terms: Neo will retain offtake rights and become a strategic shareholder of Greenland Mines upon closing of the Neo North Star Resources acquisition.